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Objectives: The objective of this study was to determine whether automated
quantification of lung perfused blood volume (PBV) in dual-energy computed
tomographic pulmonary angiography (DE-CTPA) can be used to assess the
severity and regional distribution of pulmonary hypoperfusion in emphysema.
Materials and Methods: We retrospectively analyzed 40 consecutive patients
(mean age, 67 [13] years) with pulmonary emphysema, who have no cardio-
pulmonary comorbidities, and a DE-CTPA negative for pulmonary embolism.
Automated quantification of global and regional pulmonary PBV was performed
using the syngo Dual Energy application (Siemens Healthcare). Similarly, the
global and regional degrees of parenchymal hypodensity were assessed automat-
ically as the percentage of voxels with a computed tomographic density less than
j900 Hounsfield unit. Emphysema severity was rated visually, and pulmonary
function tests were obtained by chart review, if available.
Results: Global PBV generated by automated quantification of pulmonary
PBV in the DE-CTPA data sets showed a moderately strong but highly significant
negative correlation with residual volume in percentage of the predicted residual
volume (r = j0.62; P = 0.002; n = 23) and a positive correlation with
forced expiratory volume in 1 second in percentage of the predicted forced expi-
ratory volume in 1 second (r = 0.67; P G 0.001; n = 23). Global PBV values
strongly correlated with diffusing lung capacity for carbon monoxide (r = 0.80;
P G 0.001; n = 15). Pulmonary PBV values decreased with visual emphy-
sema severity (r = j0.46, P = 0.003, n = 40). Moderate negative correlations
were found between global PBV values and parenchymal hypodensity both in
a per-patient (r =j0.63; P G 0.001; n = 40) and per-region analyses (r =j0.62;
P G 0.001; n = 40).
Conclusions: Dual-energy computed tomographic pulmonary angiography
allows simultaneous assessment of lung morphology, parenchymal density,
and pulmonary PBV. In patients with pulmonary emphysema, automated
quantification of pulmonary PBV in DE-CTPA can be used for a quick,
reader-independent estimation of global and regional pulmonary perfusion,
which correlates with several lung function parameters.
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(Invest Radiol 2013;48: 79Y85)
Chronic obstructive pulmonary disease (COPD) is one of theleading causes of morbidity and mortality worldwide.1,2 It is
characterized by airflow limitation and lung inflammation resulting
in a progressive deterioration in lung function. Emphysema is a
common component of COPD, in which airway obstruction, in-
flammation, and aberrant activity of proteolytic enzymes cause irre-
versible destruction of the alveolar walls and enlargement of distal
airspaces.3
Currently, screening for and early diagnosis of COPD and em-
physema largely rely on spirometric lung function tests.4 Spirometry,
however, strongly depends on patients’ cooperation and is unable to
localize emphysematous changes within the lung. Because pulmonary
emphysema involves a complex pathophysiology of parenchymal de-
struction and hypoxic vasoconstriction, the correlation between areas
of parenchymal destruction and areas of hypoperfusion is known to be
strong but imperfect.5,6 This reflects the complex pathophysiology of
pulmonary emphysema in which airflow obstruction, parenchymal
destruction, and hypoxic vasoconstriction all contribute to impaired
gas exchange.
Assessing the regional distribution of pulmonary emphysema
and integrating the complementary information of lung morphology
and lung perfusion are particularly relevant in the assessment of
patients with emphysema who are considered for lung volume reduc-
tion surgery (LVRS) or endobronchial interventions.7,8 A study in
25 patients showed a superior prediction of postoperative outcome
after LVRS for coregistered perfusion single-photon emission com-
puted tomography (SPECT) and computed tomography (CT) as
compared with planar scintigraphy, stand-alone SPECT, or qualitative
assessment of stand-alone CT.9 Data from more than 1000 patients
undergoing LVRS within the National Emphysema Treatment Trial
showed that LVRS reduces mortality in patients with upper
lobeYpredominant emphysema only if there is low, rather than high,
perfusion to the upper lung on scintigraphy.10 Therefore, imaging
of pulmonary emphysema should ideally assess the regional distribu-
tion of both parenchymal destruction and pulmonary perfusion
simultaneously.
Dual-energy computed tomographic pulmonary angiography
(DE-CTPA) can be used to generate iodine distribution maps of
pulmonary parenchyma,11Y15 which correspond well with pulmonary
perfusion on scintigraphy16 and SPECT17 images. Dual-energy CT
thus simultaneously provides high-resolution morphological images
of pulmonary parenchyma and functional information on pulmonary
perfusion. A small number of initial studies have applied dual-energy
CT to the quantification of pulmonary PBV in emphysema.6,18,19
These studies have confirmed a good but imperfect correlation be-
tween areas of hypodensity on virtual noncontrast scans and areas of
PBV defects on iodine distribution maps.6,18
A recently developed software allows automated quantifi-
cation of the iodine concentration in pulmonary parenchyma, poten-
tially providing a quick, reader-independent tool for the assessment of
global and regional pulmonary PBV.20 The purpose of this study was
to assess whether automated quantification of pulmonary PBV in DE-
CTPA can be used to quantify global and regional pulmonary perfu-
sion in pulmonary emphysema and to correlate DE-CTPAYderived
PBV values with visual, densitometric, and functional assessments of
pulmonary emphysema.
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MATERIALS AND METHODS
Computed Tomographic Image Acquisition
All DE-CTPAs were performed on a dual-source CT scanner
(SOMATOM Definition Flash; Siemens Medical, Forchheim, Germany).
An 85 mL of contrast material (iopromide, Ultravist 370; Bayer
Schering Pharma, Berlin, Germany) was administered via an ante-
cubitalvein at a flow rate of 5 mL/s, followed by 50 mL of saline,
which was injected at the same flow rate. Scans were started using a
bolus-tracking technique with a threshold of 100 Hounsfield unit
(HU) in the pulmonary trunk and an additional delay of 7 seconds. To
reduce streak artifacts caused by dense contrast material in the su-
perior vena cava, scans were performed in caudocranial direction. A
combination of a tin-filtered (Sn) 140Ykilovolt (peak) (kV[p]) and a
100-kV(p) spectrum was used. Collimation was set to 32  0.6 mm.
Pitch was 0.5 at a rotation time of 0.28 s/rot. Mean (SD) com-
puted tomography dose index and dose length product were 10.0
(2.5) mGy and 315 (85) mGyIcm, corresponding to an effective
radiation dose of 4.6 mSv (using a standard conversion factor for
chest CT of 0.0145 mSv/mGy  cm21).
Computed Tomographic Image Reconstruction
Computed tomographic pulmonary angiographic (CTPA) ima-
ges were reconstructed in axial orientation using a specific medium
soft convolution kernel optimized for dual-energy (DE) images (D30)
at a 1.5-mm slice thickness with a 1.0-mm increment. The tin-filtered
140-kV(p) spectrum of the second-generation dual-source scanner in
this study allows for using 100 kV(p) as the second spectrum instead
of the 80-kV(p) spectrum used in most published studies because the
filter decreases spectral overlap between both tubes. If this spectral
combination of Sn140 kV(p) and 100 kV(p) is used, an average image
with equal contributions from both spectra best corresponds to a single-
spectrum scan at 120 kV(p). Therefore, average images were generated
with equal contributions from the Sn140-kV(p) and the 100-kV(p)
data set. Dual-energy CT imaging allows for material differentiation
based on the different absorption characteristics of different types of
tissue. Iodine is known to produce higher attenuation at lower tube
voltage settings.22 Thus, the spectral information obtained at different
voltage settings allows for a 3-material decomposition differentiating
soft tissue, air, and iodine. This algorithm assigns a ratio of air and soft
tissue to each voxel and uses CT attenuation values at both energies to
derive the additional iodine content.23 Virtual noncontrast images are
generated by subtracting enhancement due to iodine from the average
images. Color-coded iodine distribution maps were generated by spe-
cific, Food and Drug AdministrationYapproved DE postprocessing
software (‘‘lung PBV’’ in syngo Dual Energy; Siemens Healthcare) on a
dedicated postprocessing workstation (syngo multimodality workplace,
Somaris Version CT2008G; Siemens Healthcare). Iodine distribution
PBV maps were superimposed onto CTPA images at a slice thickness of
3 mm with a 1-mm increment in axial, sagittal, and coronal orientations.
Image Quality Control
To ensure valid assessment of pulmonary PBV, we excluded
all examinations with substantial artifacts, inadequate enhancement
of the pulmonary vasculature, and/or inadequate timing. For this
purpose, all images considered for the study were reviewed. The
degree of artifacts in iodine distribution maps (from cardiac motion,
breathing, or concentrated contrast material) was rated on a 4-point
scale (0, no artifacts; 1, mild artifacts; 2, moderate artifacts; and 3,
severe artifacts). All studies with severe artifacts were excluded from
the study. In addition, we measured enhancement in the pulmonary
trunk and the ascending aorta. Because lung PBV values are quan-
tified by measuring the enhancement of the pulmonary parenchyma
relative to the enhancement of the pulmonary trunk, PBV values may
become unreliable with inadequate enhancement of the pulmonary
vasculature and inadequate timing of the examination relative to the
contrast bolus. Therefore, all examinations with an enhancement of
the pulmonary trunk of less than 200 HU or less than the enhance-
ment of the ascending aorta were excluded. Because this study was
performed on a second-generation dual-source scanner with an extended
field of view of 32 cm for dual-energy applications, the dual-energy
analysis fully covered the pulmonary parenchyma in all patients.
Patient Selection
We defined the following inclusion criteria:
1. DE-CTPA performed for clinical indication of suspected acute
pulmonary embolism
2. DE-CTPA negative for pulmonary embolism
3. Known pulmonary emphysema and/or pulmonary emphysema
detected on DE-CTPA
4. Informed consent provided
We defined the following exclusion criteria:
1. DE-CTPA with severe artifacts and inadequate vascular en-
hancement or timing
2. Any significant cardiopulmonary comorbidities (including signs
of congestive heart failure, pneumonia, lung masses, significant
pleural effusions or atelectasis, pneumothorax, and others)
All DE-CTPAs performed at our institution between May 2009
and November 2011 were assessed for the presence of pulmonary
embolism, pulmonary emphysema, and any cardiopulmonary comor-
bidities that might influence pulmonary PBV. We included all 40
patients with known or newly detected pulmonary emphysema, who
have no cardiopulmonary comorbidities, and DE-CTPA negative for
pulmonary embolism.
Ethical Approval and Informed Consent
Written informed consent for the CTPA examination was
obtained from all patients. Ethical approval and individual informed
consent for the retrospective data analysis were waived by the re-
sponsible ethics committee.
Computed Tomographic Data Analysis
One board-certified radiologist with more than 10 years of ex-
perience in thoracic imaging (T.R.C.J.) and 1 radiology resident (F.G.M.)
reviewed the reconstructed CTPA images in consensus, blinded to the
patients’ clinical data. Images were analyzed in axial, sagittal, and cor-
onal orientations on a postprocessing workstation (syngo multimodality
workplace using 3-dimensional mode).
Visual Rating of Emphysema Severity
Emphysema severity was rated on virtual noncontrast images
using a 5-point scale. The emphysema score was assigned on the
basis of emphysematous area involvement: 1, less than 5% (mini-
mal); 2, 5% to 25% (mild); 3, 26% to 50% (moderate); 4, 51% to
75% (severe); and 5, more than 75% (very severe).24 The predomi-
nant morphology of emphysema was classified as centrilobular,
panacinar, paraseptal, or mixed/equivocal. Bullous emphysema was
not considered a distinct subtype because bullous changes commonly
occur in all subtypes of advanced emphysema.
Automated Quantification of Pulmonary PBV
Automated quantification of pulmonary PBV was performed
using the DE lung PBV application of the syngo Dual Energy soft-
ware (version VE32B; Siemens Healthcare). This analysis quantifies
pulmonary PBV by measuring the enhancement of the pulmonary
parenchyma in relation to the enhancement of a reference vessel. The
reference vessel was defined by placing a standardized region of
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interest sized 0.5 cm2 in the pulmonary trunk on axial images. The
software calculates pulmonary PBV as (mean enhancement of the
pulmonary parenchyma in HU/mean enhancement of the pulmonary
trunk in HU)/calibration factor 0.15. For example, for a vascular
enhancement of 400 HU, a mean enhancement of the pulmonary
parenchyma of 400 HU  0.15 = 60 HU would represent a PBV of
100%. Lung isolation, lung partitioning (in the upper, middle, and
lower zones), and enhancement analysis are performed automatically.
The software then displays PBV for the entire pulmonary parenchy-
ma, the right and left lungs separately, and the lower, middle, and
upper zones of each lung separately.
Analysis of Parenchymal Density
The identical software (DE lung PBVapplication of the syngo
Dual Energy software, version VE32B; Siemens Healthcare) was
used to quantify the percentage of voxels with attenuation values
lower than j900 HU in the virtual noncontrast images for the entire
pulmonary parenchyma, the right and left lungs separately, and the
lower, middle, and upper zones of each lung separately. This cutoff
was chosen based on the literature such that healthy lungs would
have G 5% of voxels of this low density, thus making it highly spe-
cific for emphysematous parenchyma.25 Zones were automatically
defined by the software and were identical to the zones used for
PBV quantification.
Analysis of Pulmonary Function Tests
Because pulmonary emphysema can progress over time, we
only included pulmonary function tests (PFTs) performed within
6 months of the CTPA examination. For 23 of the 40 patients, PFTs
performed within 6 months of the DE-CTPA examination were
available from the patients’ charts. The forced expiratory volume in
1 second (FEV1) in percentage of the predicted FEV1 and the residual
volume (RV) in percentage of the predicted RV, as determined by
body plethysmography, were recorded and analyzed. The diffusing
capacity for carbon monoxide (DLCO) had been assessed in 15 of
these patients. If available, DLCO was recorded and included in the
analysis.
Statistical Analysis
Statistical analysis was performed using Microsoft Excel for
Mac 2001 (version 14.1.3) and IBM SPSS statistics for Mac (version
20.0.0.1). Global PBV values were correlated with visual rating
scores of emphysema severity, global parenchymal hypodensity (the
percentage of voxels with attenuation values lower than j900 HU),
and parameters of pulmonary function. Regional PBV values were
correlated with regional parenchymal hypodensity. The Spearman
correlation coefficient r was used for all correlation analyses. Values
of r from 0 to 0.29, from 0.30 to 0.69, and greater than 0.70 were
considered weak, moderate, and strong correlations.26 A 2-tailed P G
0.05 was considered statistically significant. Multivariate regression
analysis was performed to adjust for the influence of age and sex. For




Mean (SD) age was 67 (13) years with a range of 39 to 90 years
(Table 1). Of the 40 patients, 17 (43%) were women. Emphysema was
classified as predominantly centrilobular in 28 patients (70%), pana-
cinar in 8 patients (20%), paraseptal in 1 patient (3%), and equivocal in
3 patients (8%). Computed tomographic-morphologic evidence of
emphysema severity was rated as minimal in 8 patients (20%), mild in
12 patients (30%), moderate in 9 patients (23%), severe in 7 patients
(18%), and very severe in 4 patients (10%).
Correlation of Global Pulmonary PBV Values
With Age
After the adjustment for the visual severity of emphysema,
there was no significant correlation between PBV values and age
(A = 0.01; P = 0.96).
Correlation of the Global Pulmonary PBV Values
With Visual Rating and Attenuation-Based
Emphysema Quantification
A moderate but significant negative correlation was found
between visual rating scores of emphysema severity and the global
pulmonary PBV values (r = j0.46; P = 0.003; Fig. 1A), which was
confirmed as an independent correlation in multivariate regression
analysis (A = j0.35; P = 0.02). This correlation was not significant
for mild to moderate emphysema (severity scores, 1Y3). Similarly,
there was a negative correlation between the global PBV values and
the percentage of voxels within the pulmonary parenchyma with a CT
density less than j900 HU on bivariate correlation (r = j0.63; P G
0.001; Fig. 1B) and multivariate regression (A = j0.54; P G 0.001).
Region-Based Analysis: Correlation of the Regional
PBV Values and Parenchymal Density
Next, we correlated the regional PBV values and parenchymal
hypodensity for the upper, middle, and lower lung zones of each lung
as defined by automatic lung partitioning. In this per-region analysis,
a moderate correlation was observed between the regional PBV
values and regional parenchymal hypodensity quantified as the re-
gional percentage of voxels with a CT density lower than j900 HU
(r = j0.62; P G 0.001; Fig. 1C). On multivariate regression analysis,
this correlation was independent of age, sex, and global PBV values
(A = j0.43; P G 0.001).
Correlation of the Global Pulmonary PBV Values
With PFTs
Global PBV generated by automated quantification in the DE-
CTPA data sets showed a moderate but highly significant negative
TABLE 1. Patient Characteristics
No. patients 40
Indication for CTPA Suspected pulmonary embolism
Result of CTPA No pulmonary embolism
Emphysema
Known and confirmed on index
CTPA, n (%)
17 (43%)




Age, mean (SD) [range], y 67 (13) [39Y90] y
Women, n (%) 17 (43%)
Emphysema type
centrilobular, n (%) 28 (70%)
panacinar, n (%) 8 (20%)
paraseptal, n (%) 1 (3%)
equivocal, n (%) 3 (8%)
Emphysema severity
minimal, n (%) 8 (20%)
mild, n (%) 12 (30%)
moderate, n (%) 9 (23%)
severe, n (%) 7 (18%)
very severe, n (%) 4 (10%)
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correlation (r =j0.62; P = 0.002) with RV in percentage of the
predicted RV (Fig. 2A). This correlation was independent of con-
founding by age and sex, as confirmed by the multivariate regression
analysis (standardized correlation coefficient A = j0.33, P = 0.006).
Similarly, a positive correlation was found between the global
PBV values and FEV1 in percentage of the predicted FEV1 (r = 0.67;
FIGURE 1. Correlation of the pulmonary PBV values with
emphysema severity and parenchymal density. A, For all
patients (n = 40), the global pulmonary PBV values are shown in
relation to the visually determined severity of emphysema
(1, minimal; 2, mild; 3, moderate; 4, severe; and 5, very
severe). B, The global pulmonary PBV values are plotted
against the overall percentage of voxels within the pulmonary
parenchyma with a CT density less than j900 HU in the virtual
noncontrast images in a per-patient analysis (n = 40). C, For
a per-region analysis, the regional pulmonary PBV values
are plotted against the percentage of voxels with
a CT density less than j900 HU within that region.
For each patient, the left and right lungs and the upper,
middle, and lower regions were automatically defined
by the software and were identical for density and PBV analyses
(n = 240). The trend lines are shown, as determined
by linear regression analysis.
FIGURE 2. Correlation of the global pulmonary PBV values with
PFTs. For each patient with PFTs performed (n = 23), the global
pulmonary PBV values are plotted against RV in percentage of
the predicted RV (A) and against FEV1 in percentage of the
predicted FEV1 (B). The DLCO was only assessed in 15 patients.
For these patients, the DLCO in percentage of the predicted
DLCO in relation to the global pulmonary PBV (C) is shown.
The trend lines are shown, as determined by the
linear regression analysis.
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FIGURE 3. Representative images of and results from patients
with pulmonary emphysema of varying severity. Representative
images of and results from patients with visual emphysema
severity scores of 1 (minimal), 3 (moderate), and 5 (very severe) are
shown. A, Axial and coronal images similar to the standard
120-kV(p) CTPA images were generated with equal contributions
from the Sn140-kV(p) and the 100-kV(p) data set. Lung isolation,
partitioning, and densitometric analysis were performed
automatically. The percentage of voxels with a CT density less
thanj900HU is shown for the upper,middle, and lower region of
each lung and the entire lung parenchyma (below). B,
Color-coded iodine distribution maps are superimposed onto the
CTPA images in axial and coronal orientations. After the
manual definition of the pulmonary trunk as the reference vessel,
lung isolation, partitioning, and enhancement analysis were
performed automatically. Relative pulmonary parenchymal
enhancement is shown for the entire pulmonary parenchyma
and individual lung zones.
FIGURE 4. Regional heterogeneity of parenchymal changes
and pulmonary PBV. Representative images of and results from
the patients with marked regional differences in emphysema
severity. A, Axial and coronal images similar to the standard
120-kV(p) CTPA images were generated with equal
contributions from the Sn140-kV(p) and the 100-kV(p) data set.
Lung isolation, partitioning, and densitometric analysis were
performed automatically. The percentage of voxels with a CT
density less than j900 HU is shown for the upper, middle, and
lower region of each lung and the entire lung parenchyma
(below). B, Color-coded iodine distribution maps are
superimposed onto the CTPA images in axial and coronal
orientations. After the manual definition of the pulmonary trunk
as the reference vessel, lung isolation, partitioning, and
enhancement analysis were performed automatically. Relative
pulmonary parenchymal enhancement is shown for the entire
pulmonary parenchyma and individual lung zones.
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P G 0.001; Fig. 2B). Again, this correlation was confirmed in the
multivariate regression analysis (A = 0.40, P = 0.006). The global
PBV values strongly correlated with DLCO (r = 0.80; P G 0.001; n =15;
Fig. 2C). This correlation was stronger than the correlations between
DLCO and the visual degree of emphysema (r = 0.70; P = 0.004) and
between DLCO and the percentage of voxels within the pulmonary
parenchymawith a CT density less thanj900 HU (r = 0.70; P = 0.003).
Representative images and PBV values of patients with pul-
monary emphysema of varying severity are shown in Figure 3.
Figure 4 shows images and PBV values of patients with pulmonary
emphysema of marked regional heterogeneity.
DISCUSSION
Other imaging modalities such as perfusion magnetic resonance
imaging,27 perfusion scintigraphy,10 and perfusion SPECT28 can be
used to quantify pulmonary perfusion. In COPD, changes in pulmo-
nary perfusion assessed by perfusion scintigraphy or SPECT have
been shown to correlate with the extent of emphysema as assessed by
high-resolution CT and PFTs.10,28 However, these modalities are in-
ferior to multidetector CT in the depiction of lung morphology.
Coregistered SPECT/CT can combine detailed morphological assess-
ment and perfusion analysis9 at the expense of a higher radiation
dose.29 Dual-energy computed tomographic pulmonary angiography is
dose neutral compared with conventional chest CT30 and combines
excellent morphological depiction of lung parenchyma with pulmo-
nary PBV maps, which correspond well with pulmonary perfusion on
scintigraphy16 and SPECT17 images.
Interestingly, a number of studies using scintigraphy or SPECT
have shown imperfect correlations between areas with most pronounced
morphological changes and areas of decreased lung perfusion in
pulmonary emphysema.5,10,31,32 Our data are in line with these previous
results because we found only moderate correlations between the pul-
monary PBV values and the visual and densitometric degree of paren-
chymal changes both in a per-patient analysis and a per-region analysis.
We conclude that the assessments of parenchymal morphology
and pulmonary PBV on DE-CTPA are complementary sets of infor-
mation that should be considered independently. In our study, the
pulmonary PBV showed a moderately strong correlation with para-
meters of airflow obstruction and air trapping. The correlation
strength is similar to what has been found for perfusion SPECT.28
Interestingly, our study showed a strong correlation between the
pulmonary PBV values with DLCO as a global marker of lung
function, which was stronger than the correlation between DLCO and
the visual or densitometric degree of parenchymal changes. This may
indicate that some morphologically normal lung areas are hypo-
perfused, thus diminishing their contribution to gas exchange. How-
ever, this particular correlation is based on the relatively small number
of 15 patients and needs to be confirmed in larger, prospective studies.
The assessment of pulmonary perfusion in emphysema has
gained clinical significance because a recent analysis demonstrated
that LVRS reduces mortality in patients with upper lobeYpredominant
emphysema only if there is low, rather than high, perfusion to the
upper lung on scintigraphy.10 Dual-energy computed tomographic
pulmonary angiography with automated quantification of pulmonary
PBVas a single comprehensive examination could potentially replace
the combination of CTand scintigraphy or SPECT in the preoperative
assessment of candidates for LVRS. For this and other clinical
applications, the automated quantification of pulmonary PBV, as
demonstrated in this study, renders DE-CTPA more useful for clinical
routine by providing a quick, quantitative, and reader-independent
estimation of global and regional pulmonary perfusion.
The results of our study have to be seen in the context of the
study design. To avoid confounding, we excluded patients with em-
physema who have any cardiopulmonary comorbidities. However,
a significant proportion of patients with emphysema undergoing DE-
CTPA for suspected pulmonary embolism at our institution (an aca-
demic tertiary care hospital) has major cardiopulmonary comorbidities
such as primary or metastatic pulmonary malignancy, congestive
heart failure, pneumonia, or pleural effusions. The influence of these
comorbidities on DE-CTPA pulmonary PBV values in an unselected
patient population needs to be addressed in further studies.
Furthermore, this study did not compare the pulmonary PBV
values to an external standard of reference such as ventilation/per-
fusion scintigraphy and the number of patients in this study is lim-
ited. Particularly, because of incomplete data sets available for the
retrospective analysis, the correlations of imaging with PFTs and
DLCO are only based on 23 and 15 patients, respectively, and need to
be confirmed in larger studies.
Because the patients in this study underwent the CTPA ex-
amination with a suspicion of pulmonary embolism, we cannot en-
tirely rule out that hidden pulmonary embolism not detected on
CTPA may have confounded the PBV values. However, the sensi-
tivity of multidetector CTPA for pulmonary embolism falls in the
range of 83% to 89% with 4-slice and 16-slice scanners33 and is
generally assumed to be even higher with more advanced scanners
and the use of dual-energy technology. Therefore, it is very unlikely
that a substantial percentage of the patients in this study had pul-
monary emboli despite negative DE-CTPA findings.
In contrast to combined ventilation/perfusion scintigraphy and
SPECT, the standard DE-CTPA used in this study is unable to di-
rectly assess pulmonary ventilation. However, the feasibility of a
combined ventilation and perfusion dual-energy CT using inhaled
xenon has been demonstrated in patients who underwent mechanical
ventilation.34 Initial studies have demonstrated that ventilation dual-
energy CT using inhaled xenon35 or krypton36 can identify ventila-
tion abnormalities in patients with emphysema. Further studies are
needed to investigate the diagnostic value of combined ventilation
and perfusion dual-energy CT in patients with pulmonary emphysema,
particularly in the preoperative assessment of candidates for LVRS.
CONCLUSIONS
Dual-energy computed tomographic pulmonary angiography
can be used for simultaneous assessment of parenchymal morphology,
parenchymal density, and pulmonary PBV in patients with pulmonary
emphysema. On the basis of DE-CTPA data sets, automated quantifi-
cation of pulmonary PBV provides an immediate, reader-independent
quantification of global and regional lung perfusion, which correlates
with several lung function parameters. This can be integrated into the
clinical decision making regarding the medical, surgical, or endoscopic
treatment of pulmonary emphysema.
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